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Uncovering Capgras delusion using a large-scale
medical records database
Vaughan Bell, Caryl Marshall, Zara Kanji, Sam Wilkinson, Peter Halligan and Quinton Deeley
Background
Capgras delusion is scientifically important but most commonly
reported as single case studies. Studies analysing large clinical
records databases focus on common disorders but none have
investigated rare syndromes.
Aims
Identify cases of Capgras delusion and associated
psychopathology, demographics, cognitive function and
neuropathology in light of existing models.
Method
Combined computational data extraction and qualitative
classification using 250 000 case records from South London and
Maudsley Clinical Record Interactive Search (CRIS) database.
Results
We identified 84 individuals and extracted diagnosis-matched
comparison groups. Capgras was not ‘monothematic’ in the
majority of cases. Most cases involved misidentified family
members or close partners but others were misidentified in
25% of cases, contrary to dual-route face recognition models.
Neuroimaging provided no evidence for predominantly right
hemisphere damage. Individuals were ethnically diverse with a
range of psychosis spectrum diagnoses.
Conclusions
Capgras is more diverse than current models assume.
Identification of rare syndromes complements existing
‘big data’ approaches in psychiatry.
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Capgras delusion is the delusional belief that someone, often a
family member or close relative, has been replaced by similar-
looking impostor or double.1–3 Although considered rare, cases
of Capgras delusion have played an important role in the history
and development of the science of psychopathology. It was one
of the founding areas of research in cognitive neuropsychiatry4
and continues to be conceptually important in the development
of cognitive theories of delusions.5–7 Anonymised data from
electronic health records have been used to conduct large-scale
psychiatric studies on common disorders, allowing associations to
be observed in very large data-sets. However, these data-sets
would also allow for a different approach: the identification of
relatively large series of very rare disorders, along with a rich set
of clinical data to elucidate psychopathology and its neuropsycho-
logical and neuropathological associations. The use of ‘big data’ to
identify rare cases has been discussed in cancer genomics,8 but it
has not yet been applied to psychiatry.
One of the challenges of using medical record databases for
cognitive neuropsychiatry is that many rare syndromes, like
Capgras, do not have a specific diagnostic code and are usually
documented in narrative written notes. Therefore, a combined
approach is needed that involves manual classification combined
with methods of computational data extraction. This is the
approach taken by this study, where we used a high-specificity
search strategy to identify cases in a large anonymised database of
clinical records, which were then analysed to examine demo-
graphics, psychopathology, cognitive function and neuropathology
associated with the presence of Capgras delusion. Our aim was to
examine assumptions about the condition that have largely been
based on single-case studies and explore their implications for
theories of delusion formation, both as an investigation of the
delusion itself and as a test case for the use of large clinical data-
sets to identify rare psychiatric syndromes.
Method
The study used the Clinical Record Interactive Search (CRIS)
system, an electronic research database of anonymised clinical
records from the South London and Maudsley NHS Foundation
Trust (SLaM) – the public service provider for secondary and
tertiary mental health services for four London boroughs
(Lambeth, Southwark, Lewisham and Croydon) with a total
population of about 1.2 million residents. The CRIS system
contains anonymised health records for over 250 000 people
starting in 2008. Over this time period, SLaM has provided almost
the entire range of public mental health services for the population
across the lifespan and across presentation types as well as a
range of local and national specialist services. Technical details
of the CRIS system are reported in Stewart et al.9 Details of the
CRIS patient cohort used for this study, including statistics for
demographics and diagnoses in the sample, are reported in Perera
et al.10 Ethical approval as an anonymised database for secondary
analysis was originally granted in 2008, and renewed for a further
5 years in 2013 (Oxford C Research Ethics Committee, reference
08/H0606/71+5). Data extraction procedures and stages are
illustrated in Fig. 1.
Case selection
Preliminary use of the keyword ‘Capgras’ indicated it had
sufficient specificity to identify candidate records for manual
classification based on an informal inspection (‘eyeballing’) of a
selection of retrieved case records. The keyword ‘Capgras’ was
then used in a formal search of free-text record fields, retrieving
records from 187 patients. Previous case-identification studies
have tended to select cases based on informal labels used by
consulting clinicians,11 or single-rater review of case notes using a
brief description of the delusion (see Tamam et al12). In this study,
the 187 anonymised records were subsequently independently
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rated by a psychiatrist and clinical psychologist for the likely
presence of Capgras delusion using the structured classification
system described in Fig. 2. The features of Capgras delusion were
based on standard definitions in the literature1–3 and were drawn
up to avoid misclassification of a closely related delusional
misidentification syndrome (Fregoli delusion13) to ensure Capgras
would be specifically identified.
Cohen’s kappa was used to assess the level of independent
agreement between raters, with κ=0.749 indicating an acceptable
level of agreement. After independent rating, disagreements were
resolved by discussion between raters. Consequently, 20 cases
were classified as not Capgras, 20 cases as past Capgras only,
63 cases as Capgras possibly present and 84 cases were classified
as strongly indicating the presence of Capgras delusion. Only
the last cases were retained for subsequent analysis. The date
of the record from which raters first identified strong evidence
of Capgras for each case was noted (henceforth referred to as
the date of ‘Case ID’) and used for subsequent analyses. Data
extraction for comparison groups is described in the relevant
sections below.
Data extraction
Data for demographics and primary diagnosis were extracted
directly from specific database fields. Symptom phenomenology
and service context were collaboratively extracted by the two
raters from written records. Data for neuroimaging assessment
results (computed tomography (CT), magnetic resonance imaging
(MRI) and electroencephalography (EEG)) were extracted from
reports arising from the assessments (original images of scans
and/or EEG charts were not available). Data for antipsychotic
medication and Mini-Mental State Examination (MMSE) score for
identified cases were extracted through the use of specific CRIS
text-mining applications built using the General Architecture for
Text Engineering machine-learning framework based on natural
language-processing techniques, a system described in Perera
et al.10 At the time of data extraction, the medication extraction
application had a precision (equivalent to specificity) of 0.94
and a recall (sensitivity) of 0.57, and the MMSE application had
a precision of 0.91 and a recall of 0.88 (M. Broadbent, 2016,
personal communication). Comparison samples for MMSE and
neuroimaging results were derived post hoc to match the Capgras
sample and are detailed in the relevant sections below. Statistics
were calculated using R version 3.3.2.
Results
Demographics
Cases consisted of 56 females and 28 males. The mean age at date
of Case ID date was 44.6 years (s.d.=19.4, range 14.7–94.8).
The sample was ethnically diverse. Ethnicity was classified as
British (n=36), African (n=16), any other White background (n=8),
any other Black background (n=6), Caribbean (n=6), any other
ethnic group (n=5), any other Asian background (n=2), Pakistani
(n=2), any other mixed background (n=1), Chinese (n=1) and
Indian (n=1). Out of the total cases, 50 did not have information for
country of origin but for the 34 that did they were classified as the
UK (n=23), Nigeria (n=3), Cyprus (n=2), Ghana (n=2), Italy (n=2),
Jamaica (n=2) and Yemen (n=2). One case from each of the
following countries of origin was recorded: Brazil, Congo, Cote
d’Ivoire, Croatia, England, France, Hong Kong, India, Pakistan,
Portugal, Romania, Sierra Leone, Somalia and Sri Lanka.
Service context
Out of the 84 cases, 16 individuals were presenting to mental
health services for the first time at the date of Case ID, 60 had a
history of contact with mental health services and in the
remaining 8 cases past contact was not clear from the retrieved
information. Case ID was based on a record where a mental state
examination was reported by a psychiatrist or trainee psychiatrist
in 54 cases.
Diagnosis
Of the 84 cases, 69 individuals had existing diagnoses at the time
of Case ID (Table 1). Considering previously reported associations
between Capgras delusion and dementia,14 we examined the
number of patients with Capgras at Case ID converted to dementia
from other diagnoses. Over the total recorded contact with mental
Case review and 
classification by clinicians 
n = 84 confirmed 
Keyword case filtering 
n = 187 
Database field 
data extraction 
Machine learning 
data extraction 
Manual data 
extraction 
CRIS clinical records database
n = 250 000+ 
Fig. 1 Capgras case data extraction procedure. CRIS, Clinical
Records Interactive Search.
Strongly: Capgras is mentioned as a present delusion plus evidence of present or recent
relevant delusional misidentification of people is described (mention of people being replaced,
or impostors, or lookalikes, or identical looking people, or clones, or robots etc).
Possibly: Capgras is mentioned as a present delusion but no additional description of delusion
content is given, or delusional nature is questioned, or the description is clearly not person
misidentification.
Not present: Capgras is excluded, or mentioned erroneously, or conflicts with the description
of the delusion (clearly not misidentification).
Only past: Capgras delusion is only mentioned as previously present with no evidence of
current misidentification, or is described as fully resolved.
Fig. 2 Categories and deﬁnitions for case note classiﬁcation used by independent raters.
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health services, nine individuals received a diagnosis of dementia,
four held a dementia diagnosis at time of Case ID, and five
converted to a primary diagnosis of dementia from a primary
diagnosis of depressive disorder (n=2), schizophrenia (n=1),
delirium not superimposed on dementia (n=1) and mental
disorders not otherwise specified (n=1).
In light of similar debates about the relationship between
Capgras and the diagnoses of schizophrenia, delusional disorder
and organic psychosis,15 we examined the transition to these
diagnoses in the sample.
Although only 23 patients had a diagnosis of schizophrenia or
paranoid schizophrenia at the time of Case ID, 39 received a
schizophrenia or paranoid schizophrenia diagnosis during their
total recorded contact with mental health services. Last recorded
diagnosis for this cohort of 39 included schizophrenia or paranoid
schizophrenia for 31 individuals, schizoaffective disorder in 3
cases, Alzheimer’s disease in 1 case, ‘unspecified mental disorder
because of brain damage and dysfunction and to physical disease’
in 1 case, ‘mental disorder not otherwise specified’ in 1case, and
‘person with feared complaint in whom no diagnosis’ made in
1 case.
In total, six individuals had a diagnosis of delusional disorder
during their total recorded contact with mental health services
(three at date of Case ID). Final diagnoses for this cohort included
delusional disorder (n=4) and schizophrenia/paranoid schizophre-
nia (n=2).
There were no individuals with a primary diagnosis of any
ICD-10 F06 category organic mental disorder at date of Case ID
and only one that had such a diagnosis during their total recorded
contact with mental health services. This patient’s last recorded
primary diagnosis was a moderate depressive episode.
Symptom phenomenology
Details of the Capgras delusion were extracted from the text of the
records and were categorised collaboratively by two raters. Totals
sum to more than the total number of cases because of some
patients having more than one delusion or a belief that could be
classified in various ways.
The individual of the delusional replacement was a family
member or close partner in 71 out of 84 cases. Non-family or non-
partner misidentification was reported in 21 cases and included
a care professional or professionals (doctor, care staff) in 9 cases,
a friend or friends in 6 cases, an acquaintance or strangers in 3 cases,
the police in 2 cases, a solicitor in 1 case, and unknown or not
specified in 4 cases (the individual was referred to but not specified
in the text or the individual was referred to in general terms – e.g.
‘people’). Twelve cases had non-family and non-partner misiden-
tification only and nine had a combination of family and non-
family or partner misidentification. In addition, three of the
identified cases involved beliefs that the patients themselves had
personally been replaced. The delusional belief was described as
involving the replacement of more than one person in 33 cases.
The identity of the ‘replacer’ was described in terms of a
specific agent or agents in 10 cases (e.g. a ‘swami’, ‘someone called
(male name)’, ‘police officers’). Family members featured as the
described ‘replacer’ in three cases (‘father and father’s girlfriend’,
‘uncle’, ‘brother’) and a supernatural agent featured as a replacer in
one case (‘jinn’).
In 59 cases, there was no record of patient-reported justifica-
tion for the belief. In 10 cases, physical appearance was cited and
these ranged from seeing an ‘identical-looking person in an
unexpected location’, ‘appearance had changed (eyes, improved
skin, body shape)’, a lack of resemblance to a spouse despite
taking his or her place in the home, looking similar but being of
smaller body type, the patient’s children looking older than
expected, and an externally visible eye problem in the individual
that was perceived as being on the ‘wrong side’ of the face. In
seven cases, what were likely to be delusional explanations were
reported (e.g. another person inside the patient informed them of
the impostors, the patient met her dead sister in a local shop,
police are being covered by a membrane that disguises them). In
six cases, altered behaviour or personality was reported as the
justification (e.g. being told to ‘do this do that’ which is out of
character for the person who was ‘replaced’, ‘replaced’ person had
a ‘cold attitude’, frequent arguing with the ‘replaced’ person). In
four cases, alterations in the sound of the individual’s voice were
reported as justification (e.g. voice sounded fake on the phone,
voice sounded different). In two cases, likely auditory hallucina-
tions or thought insertion were cited (receiving messages from
Interpol informing the patient of the impostors, information from
external auditory hallucinations). In one case, a ‘sense’ that the
person was different was reported, in one case ‘hearsay’ was given
as justification, and in one case a likely visual hallucination of
seeing the person’s face in other faces was reported.
Of the 84 cases of likely Capgras delusion, 61 were reported as
having other non-Capgras-related delusions whereas the remain-
ing 23 had only Capgras-themed delusions reported. Twenty-four
out of the 84 cases were reported as experiencing auditory
hallucinations at time of Case ID.
Cognition
Scores from the MMSE16 were available for 20 cases with a total
of 70 data points. Mean MMSE scores were calculated for each
patient by creating a patient average if there was more than one
MMSE score on record, and then calculating the mean for the
sample. Mean MMSE score for Capgras cases was 21.28 (s.d.=6.12).
As a comparison, 50 patients with MMSE scores were randomly
selected from the CRIS database for each of the following
diagnoses: depression (MMSE mean 23.87; s.d.=4.59), schizophre-
nia (MMSE mean 23.09; s.d.=5.75), F28/F29 other or unspecified
nonorganic psychosis (MMSE mean 23.48; s.d.=5.73), dementia
in Alzheimer’s disease (MMSE mean 18.95; s.d.=6.62). Score
distributions for the Capgras cases and comparison samples are
presented in Fig. 3.
Table 1 Diagnoses at date of case identification
ICD-10
code Diagnosis n
F20 Schizophrenia or paranoid schizophrenia 23
F28/F29 Other or unspecified nonorganic psychotic disorders 8
F99 Mental disorder, not otherwise specified 7
F32 Depressive episode 6
F00 Dementia in Alzheimer’s disease 4
F23 Acute and transient psychotic disorders 4
F31 Bipolar affective disorder 4
F22 Delusional disorder 3
F25 Schizoaffective disorders 3
Z71.1 Person with feared complaint in whom no diagnosis
is made
2
F05.0 Delirium not superimposed on dementia, so described 1
F11.1 Mental and behavioural disorders because of use of
opioids; opioid abuse
1
F19.8 Mental and behavioural disorders because of multiple-
drug use and use of other psychoactive substances:
Other mental and behavioural disorders
1
F41.1 Generalised anxiety disorder 1
F43.1 Post-traumatic stress disorder 1
– No diagnosis 15
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Neuroimaging assessment results
Of the 84 Capgras cases, 40 had results from neuroimaging
assessments available. Records for a comparison sample (n=84)
were extracted on the basis of primary diagnosis matching where
an equivalent number of cases for each diagnosis in the Capgras
sample were randomly matched from cases in the clinical records
database with the same primary diagnosis. Fifteen Capgras cases
had no recorded diagnosis at the time of Case ID. We matched
these ‘no diagnosis’ patients with additional randomly selected
cases of people diagnosed with schizophrenia rather than other
‘no diagnosis’ patients to ensure consistent matching with a
psychotic disorder diagnosis.
Of the 40 cases in the Capgras sample with any available
neuroimaging assessment results, 26 had CT scans, 16 had
MRI scans, and 8 had EEGs. Regardless of the availability of
assessment results, 54 had a neuroimaging assessment recom-
mended. For the comparison sample, 22 cases had any neuroima-
ging results available (12 CT, 7 MRI, 3 EEG) and 37 had
a neuroimaging assessment recommended. When tested with
χ2 using Monte Carlo permutation, Capgras individuals were
significantly more likely to have neuroimaging recommended
(χ2=6.929, P=0.0138) and more likely to have neuroimaging results
available (χ2=10.37, P=0.0031). We compared the frequency of
abnormal results in Capgras and comparison samples for each
imaging type: CT (Capgras=11, comparison=4), MRI (Capgras=2,
comparison=2) and EEG (Capgras=2, comparison=0). When
tested with χ2 using Monte Carlo permutation over the whole
sample, abnormal results were not significantly more common in
the Capgras sample than the comparison sample for any imaging
modality. Of the 14 Capgras cases with abnormal neuroimaging
assessments, right-hemisphere pathology was the least common:
9 patients had diffuse pathological changes, 7 had left-sided
changes, 3 had right-sided changes and 1 had a reported result with
unclear lateralisation. Two patients had ambiguously reported
results. Tables detailing the abnormal findings in the Capgras and
comparison samples are presented in the Data supplement
(Tables DS1 and DS2).
Antipsychotic prescribing
Out of the 84 patients, 66 had a recorded antipsychotic prescrip-
tion history. The most commonly prescribed antipsychotic
medications were olanzapine (40 cases), risperidone (37 cases),
aripiprazole (24 cases), quetiapine (15 cases), haloperidol (13 cases),
zuclopenthixol (9 cases), amisulpride (7 cases), paliperidone (7 cases),
flupenthixol (6 cases), clozapine (5 cases), fluphenazine (4 cases),
pipotiazine (4 cases), trifluoperazine (4 cases), chlorpromazine
(3 cases) and sulpiride (2 cases).
Discussion
Using a combination of computational data extraction and
qualitative classification, we searched over 250 000 case records
and identified 84 cases of Capgras delusion and extracted delusion
characteristics, demographics, MMSE results and neuropathologi-
cal findings, finding that Capgras cases as described in clinical
records are more diverse than models of the Capgras delusion
assume.
Implications for cognitive models and syndromal
definition
The most common subject of the misidentification was a family
member or partner but in a significant minority of cases the
subjects included friends, acquaintances, care professionals or
strangers. There are no diagnostic criteria or official definitions
of Capgras delusion, but it is typically described as involving a
belief that a close relative or family member has been replaced by
an identical or near-identical-looking impostor.1–3
From the perspective of cognitive models of Capgras that
explain the delusion in terms of an inference based on the lack of
an expected emotional response from the face of a familiar or
close individual (‘she looks like my mother, but doesn’t feel like
her’)17–19 these misidentifications involving mere acquaintances or
strangers are hard to explain. This suggests two alternatives: either
that ‘familiar-person Capgras’ and ‘non-familiar person Capgras’
are distinct syndromes that might need to be explained via
neuropsychologically distinct causal pathways, or that cognitive
models that don’t rely on the familiar or non-familiar distinction
may more accurately capture the full range of clinical presenta-
tions (see Wilkinson20,21). The extent to which different presenta-
tions should equally be considered ‘Capgras’ given its traditional
definition is perhaps an argument over semantics. However,
we note in this case that the debate could be informed by
neuropsychological testing: a putative ‘non-familiar person Cap-
gras’ might be a stronger candidate as a distinct syndrome if
affected people show an unconscious recognition response for
familiar faces that is apparently missing in traditionally defined
Capgras, assuming that the original studies17–19 are sound.
Notably, Capgras was most commonly present in the context
of other delusions, contrary to its typical characterisation as a
‘monothematic delusion’.22 It was also identified in people with
the full range of psychotic disorder diagnoses as well as dementia
diagnoses and patients who had no pre-existing diagnoses. In
terms of demographics, the typical profile was middle-aged,
previous contact with mental health services and more likely to
be female by a ratio of 2:1. Patients gave a range of self-report
justifications for their delusions. The marked ethnic and cultural
diversity in the sample reflects the high levels of ethnic diversity in
the catchment area but also raises the question as to whether
Capgras delusion is a fundamental aspect of psychosis shared
widely across cultures. This is not to say that Capgras delusion is
‘culturally impenetrable’. Analysis of the symptom phenomenol-
ogy showed clear cultural influence (with jinn and a religious
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Fig. 3 MMSE score box plot for Capgras cases and comparison
samples. Sz, schizophrenia; F28/F29 psychosis; other/unspeciﬁed
nonorganic psychotic disorders.
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leader featuring). However, the evidence here tentatively suggests
that the core features of misidentification may well be best
accounted for in terms of universal cognitive mechanisms.
Neurocognition
Cognition in the Capgras group fell in the mid-point between the
depression, schizophrenia and unspecified non-organic psychoses
comparison samples, and the Alzheimer’s comparison sample,
although there was a marked overlap in performance between all
groups and no specific conclusions can be drawn from these data.
Additionally, the MMSE is a relatively simple ‘bedside’ cognitive
screening test and was only available for a limited number of
cases.
In terms of neuroimaging, clinically abnormal results were
more common in Capgras cases than the diagnosis-matched
comparison sample, although this was non-significant when tested
statistically. Furthermore, the type of abnormalities reported in the
Capgras cases were diagnosable but typically minor or likely-
incidental changes which are typical for clinical assessments in
psychosis23 with only a small number of discrete lesions. Clinical
definitions of Capgras often include right-hemisphere pathology1,2
or suggest it is strongly linked or even indicative of right-
hemisphere neuropathology,24,25 although this presentation was
actually the least prevalent in the sample reported here.
In interpreting the significance of assessment results taken
from clinical records, one concern is confounding by indication
where, in the case of assessments, those who present with risk
factors for a pathology are more likely to receive assessments
confirming the pathology, potentially biasing prevalence estimates.
In this instance, individuals who present with indicators of
neuropathology might be more likely to receive neuroimaging
assessments. Indeed, we confirmed that the presence of Capgras
delusion predicted both recommendations for neuroimaging and
the presence of neuroimaging results when compared with a
diagnosis-matched control group, suggesting that Capgras is being
considered as a potential indicator of neuropathology by clinicians,
in line with implications in the literature. However, confounding
by indication should lead to an over-detection of neuropathology
and yet there was still no reliable evidence for higher rates of
neuropathology in the Capgras group compared with a diagnosis-
matched control group, and no evidence for a higher frequency of
right-hemisphere lesions.
Nevertheless, in a recent review of 61 cases of lesion-related
Capgras, right-lateralised neuropathology predominated.26 The
distinction between lesion and non-lesion-related Capgras is not
consistently made in the literature and the results reported here
suggest that for individuals who present to psychiatric services, the
delusion is unlikely to be a reliable indicator of gross neuropathol-
ogy on its own. It is worth noting that existing research has still yet
to adequately compare lesion and non-lesion-related Capgras in
terms of presenting features, so it is not clear to what extent they
represent different aetiologies underlying a similar psychopathol-
ogy, or to what extent Capgras delusion in the context of clear
neuropathology has a distinct phenomenological presentation.
From a clinical perspective, it is notable that, at least within
the sample presented here, neuroimaging seems to be over-
recommended whereas the MMSE, a brief basic cognitive test
typically used in screening for dementia, was frequently used. It is
possible that the motivation for the use of this form of cognitive
screening is the belief that Capgras delusion ‘necessarily indicates
an organic syndrome’ (for which we find no evidence here),
or perhaps is motivated by knowledge of prior evidence that
misidentification delusions correlate with MMSE score in
Alzehimer’s disease.27 However, there is no evidence from our
sample that MMSE score differentiates between Capgras and
comparison groups, although this can only be adequately tested
through a formal study where collection of cognitive data is not
based on clinical judgement.
Methodological implications
Methodologically, this study illustrates the potential contribution
of ‘mining’ electronic health records for the identification of large
case series of presumably rare conditions, their associated clinical
features and factors relevant to causal models. A previous review
of lesion-related Capgras delusion reported a modal number of
cases per publication of 1,26 and we assume from other published
cases that the same is true for the Capgras literature as a whole.
Considering that research on rare conditions has been influential
in cognitive neuropsychiatry, which aims to better understand typical
neuropsychological processes through studying altered functioning,
we suggest that the use of large medical records databases may be an
important complement to existing neuropsychiatry research.
The approach taken here – first filtering by keyword, then
submitting those records to case identification by clinicians using
structured criteria, and then using database field and machine-
learning data extraction on identified cases – aimed for high-
specificity case identification. This allowed the efficient identification
of a large case series when compared to the existing scientific
literature but did not control false negative rate in terms of the
medical records database being studied, and therefore cannot give an
estimate of prevalence. For example, there may have been many
more cases of Capgras delusion that could be clearly identified based
on case description but which were not recorded using the word
‘Capgras’. Indeed, high rates of false negatives in this study are
suggested by previous studies on delusions in Alzheimer’s disease
that have reported relatively high rates of misidentification delusions
(34.2%28) and Capgras delusion (10%14), suggesting many more
cases are likely to be present than have been detected by our methods,
particularly given the fact that over 2000 dementia patients have been
reported in previous studies using the same clinical records database
that was used in this study.29
Our method for identifying cases took advantage of the fact
that Capgras is relatively well known, largely because of having an
impact on the science of psychopathology beyond its typical
prevalence in the clinic, meaning it is more likely to be identified
and recorded as ‘Capgras’ in the medical notes by clinicians.
However, this approach may not be as effective for other
syndromes that may be scientifically interesting but less likely to
be described by clinicians using specific searchable text.
One potential solution to the problems of estimating pre-
valence and identifying lesser-known rare psychiatric syndromes
would be to identify cases using clinician-assisted case identifica-
tion to (i) create a training set of genuine cases and then (ii) train
machine-learning text classification algorithms to identify further
cases in the wider database. Supervised learning algorithms such
as support vector machines have already proved efficient in
identifying further cases when trained on pre-classified text from
written notes30 and biomedical data31 and these techniques have
the potential to form the basis of epidemiological studies or case
identification for further investigation.
Limitations
We are aware that the data included in this study were obtained
from clinical notes and rely on recording by clinicians. Here,
simple error or more frequently clinician’s bias may play an
important role in terms of what is recorded, or indeed, asked about
in clinical interviews, and we are aware that there may be
additional aspects of the experience, phenomenology or medical
history that were simply not recorded. With regard to computa-
tional data extraction, the natural language processing algorithm
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for extracting MMSE data had a high precision and recall but the
algorithm for extracting antipsychotic prescription had poor recall,
meaning antipsychotic prescription was likely underestimated. As
noted previously, results from cognitive and neuroimaging assess-
ments may have been subject to confounding by indication. This is
less a concern in reference to hypotheses that Capgras is indicative
of gross right-hemisphere pathology, where we are looking to
disconfirm the hypothesis and confounding by indication would
lead to over-detection, but it does mean that broader general-
isations from the neuroimaging data outside this specific hypoth-
esis must involve significant caveats.
It is also worth noting that CT scans were more common than
MRI scans in both the case and comparison samples. Although
CT scans have a high sensitivity for space-occupying lesions,
bleeds, strokes and malformations, they do not, for example, have
the same sensitivity as MRI scans for contusions, shearing injuries
and subdural or epidural haematomas,32 meaning some lesions
may have been missed by CT assessment. Nevertheless, we have
no reason to suspect that these differences biased the results in
terms of the detection of lateralised neuropathology. However,
neither scan type was able to detect functional brain differences
above and beyond specific lesions, which have been reported in
previous Capgras studies that used functional magnetic resonance
imaging (fMRI)33 or single-photon emission computed tomogra-
phy (SPECT).34 EEG was the only imaging type reported here that
could potentially detect functional alterations and was the least
common in our sample.
In sum, we report the use of large medical records database for
rare syndrome identification in psychiatry and applied this to
Capgras delusion, showing clinical features to be more diverse
than has previously been reported in the literature, suggesting that
existing cognitive models, important for wider theories of delusion
formation, must account for a wider range of presentation and
causal pathways. It also seems that portrayals of Capgras as a
syndrome of ‘right-hemisphere organic dysfunction’ in psychiatry
are inaccurate given that this presentation was rare, and additional
clarity and detail is needed in scientific descriptions of the
syndrome to account for this diversity.
One additional implication of this study is that descriptive
psychopathology and carefully recorded phenomenological inter-
viewing beyond diagnosis is more, not less relevant, in the age of
‘big data’ analytics and electronic health records, as it has the
potential to identify rare and important psychiatric syndromes –
either as they are currently defined or as they could be discovered
amid the data.
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